BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19088016)

  • 1. Genetic susceptibility loci for breast cancer by estrogen receptor status.
    Garcia-Closas M; Chanock S
    Clin Cancer Res; 2008 Dec; 14(24):8000-9. PubMed ID: 19088016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
    Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
    PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
    Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
    Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
    Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.
    Liang J; Chen P; Hu Z; Shen H; Wang F; Chen L; Li M; Tang J; Wang H; Shen H
    Breast Cancer Res Treat; 2010 Nov; 124(1):237-41. PubMed ID: 20213080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
    Broeks A; Schmidt MK; Sherman ME; Couch FJ; Hopper JL; Dite GS; Apicella C; Smith LD; Hammet F; Southey MC; Van 't Veer LJ; de Groot R; Smit VT; Fasching PA; Beckmann MW; Jud S; Ekici AB; Hartmann A; Hein A; Schulz-Wendtland R; Burwinkel B; Marme F; Schneeweiss A; Sinn HP; Sohn C; Tchatchou S; Bojesen SE; Nordestgaard BG; Flyger H; Ørsted DD; Kaur-Knudsen D; Milne RL; Pérez JI; Zamora P; Rodríguez PM; Benítez J; Brauch H; Justenhoven C; Ko YD; ; Hamann U; Fischer HP; Brüning T; Pesch B; Chang-Claude J; Wang-Gohrke S; Bremer M; Karstens JH; Hillemanns P; Dörk T; Nevanlinna HA; Heikkinen T; Heikkilä P; Blomqvist C; Aittomäki K; Aaltonen K; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Kauppinen JM; Kataja V; Auvinen P; Eskelinen M; Soini Y; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; Holland H; ; ; Lambrechts D; Claes B; Vandorpe T; Neven P; Wildiers H; Flesch-Janys D; Hein R; Löning T; Kosel M; Fredericksen ZS; Wang X; Giles GG; Baglietto L; Severi G; McLean C; Haiman CA; Henderson BE; Le Marchand L; Kolonel LN; Alnæs GG; Kristensen V; Børresen-Dale AL; Hunter DJ; Hankinson SE; Andrulis IL; Mulligan AM; O'Malley FP; Devilee P; Huijts PE; Tollenaar RA; Van Asperen CJ; Seynaeve CS; Chanock SJ; Lissowska J; Brinton L; Peplonska B; Figueroa J; Yang XR; Hooning MJ; Hollestelle A; Oldenburg RA; Jager A; Kriege M; Ozturk B; van Leenders GJ; Hall P; Czene K; Humphreys K; Liu J; Cox A; Connley D; Cramp HE; Cross SS; Balasubramanian SP; Reed MW; Dunning AM; Easton DF; Humphreys MK; Caldas C; Blows F; Driver K; Provenzano E; Lubinski J; Jakubowska A; Huzarski T; Byrski T; Cybulski C; Gorski B; Gronwald J; Brennan P; Sangrajrang S; Gaborieau V; Shen CY; Hsiung CN; Yu JC; Chen ST; Hsu GC; Hou MF; Huang CS; Anton-Culver H; Ziogas A; Pharoah PD; Garcia-Closas M
    Hum Mol Genet; 2011 Aug; 20(16):3289-303. PubMed ID: 21596841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
    Mulligan AM; Couch FJ; Barrowdale D; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Robson M; Sherman M; Spurdle AB; Wappenschmidt B; Lee A; McGuffog L; Healey S; Sinilnikova OM; Janavicius R; Hansen Tv; Nielsen FC; Ejlertsen B; Osorio A; Muñoz-Repeto I; Durán M; Godino J; Pertesi M; Benítez J; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Bonanni B; Viel A; Pasini B; Papi L; Ottini L; Savarese A; Bernard L; Radice P; Hamann U; Verheus M; Meijers-Heijboer HE; Wijnen J; Gómez García EB; Nelen MR; Kets CM; Seynaeve C; Tilanus-Linthorst MM; van der Luijt RB; van Os T; Rookus M; Frost D; Jones JL; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Cook J; Donaldson A; Dorkins H; Gregory H; Eason J; Houghton C; Barwell J; Side LE; McCann E; Murray A; Peock S; Godwin AK; Schmutzler RK; Rhiem K; Engel C; Meindl A; Ruehl I; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Kast K; Preisler-Adams S; Varon-Mateeva R; Schoenbuchner I; Fiebig B; Heinritz W; Schäfer D; Gevensleben H; Caux-Moncoutier V; Fassy-Colcombet M; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Hardouin A; Berthet P; Muller D; Fricker JP; Mortemousque I; Pujol P; Coupier I; Lebrun M; Kientz C; Longy M; Sevenet N; Stoppa-Lyonnet D; Isaacs C; Caldes T; de la Hoya M; Heikkinen T; Aittomäki K; Blanco I; Lazaro C; Barkardottir RB; Soucy P; Dumont M; Simard J; Montagna M; Tognazzo S; D'Andrea E; Fox S; Yan M; Rebbeck T; Olopade O; Weitzel JN; Lynch HT; Ganz PA; Tomlinson GE; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Szabo C; Offit K; Sakr R; Gaudet M; Bhatia J; Kauff N; Singer CF; Tea MK; Gschwantler-Kaulich D; Fink-Retter A; Mai PL; Greene MH; Imyanitov E; O'Malley FP; Ozcelik H; Glendon G; Toland AE; Gerdes AM; Thomassen M; Kruse TA; Jensen UB; Skytte AB; Caligo MA; Soller M; Henriksson K; Wachenfeldt vA; Arver B; Stenmark-Askmalm M; Karlsson P; Ding YC; Neuhausen SL; Beattie M; Pharoah PD; Moysich KB; Nathanson KL; Karlan BY; Gross J; John EM; Daly MB; Buys SM; Southey MC; Hopper JL; Terry MB; Chung W; Miron AF; Goldgar D; Chenevix-Trench G; Easton DF; Andrulis IL; Antoniou AC; ; ; ; ; ; ; ;
    Breast Cancer Res; 2011; 13(6):R110. PubMed ID: 22053997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
    Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
    Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19p13.1 is a triple-negative-specific breast cancer susceptibility locus.
    Stevens KN; Fredericksen Z; Vachon CM; Wang X; Margolin S; Lindblom A; Nevanlinna H; Greco D; Aittomäki K; Blomqvist C; Chang-Claude J; Vrieling A; Flesch-Janys D; Sinn HP; Wang-Gohrke S; Nickels S; Brauch H; ; Ko YD; Fischer HP; Schmutzler RK; Meindl A; Bartram CR; Schott S; Engel C; Godwin AK; Weaver J; Pathak HB; Sharma P; Brenner H; Müller H; Arndt V; Stegmaier C; Miron P; Yannoukakos D; Stavropoulou A; Fountzilas G; Gogas HJ; Swann R; Dwek M; Perkins A; Milne RL; Benítez J; Zamora MP; Pérez JI; Bojesen SE; Nielsen SF; Nordestgaard BG; Flyger H; Guénel P; Truong T; Menegaux F; Cordina-Duverger E; Burwinkel B; Marmé F; Schneeweiss A; Sohn C; Sawyer E; Tomlinson I; Kerin MJ; Peto J; Johnson N; Fletcher O; Dos Santos Silva I; Fasching PA; Beckmann MW; Hartmann A; Ekici AB; Lophatananon A; Muir K; Puttawibul P; Wiangnon S; Schmidt MK; Broeks A; Braaf LM; Rosenberg EH; Hopper JL; Apicella C; Park DJ; Southey MC; Swerdlow AJ; Ashworth A; Orr N; Schoemaker MJ; Anton-Culver H; Ziogas A; Bernstein L; Dur CC; Shen CY; Yu JC; Hsu HM; Hsiung CN; Hamann U; Dünnebier T; Rüdiger T; Ulmer HU; Pharoah PP; Dunning AM; Humphreys MK; Wang Q; Cox A; Cross SS; Reed MW; Hall P; Czene K; Ambrosone CB; Ademuyiwa F; Hwang H; Eccles DM; Garcia-Closas M; Figueroa JD; Sherman ME; Lissowska J; Devilee P; Seynaeve C; Tollenaar RA; Hooning MJ; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; John EM; Miron A; Alnæs GG; Kristensen V; Børresen-Dale AL; Giles GG; Baglietto L; McLean CA; Severi G; Kosel ML; Pankratz VS; Slager S; Olson JE; Radice P; Peterlongo P; Manoukian S; Barile M; Lambrechts D; Hatse S; Dieudonne AS; Christiaens MR; Chenevix-Trench G; ; ; Beesley J; Chen X; Mannermaa A; Kosma VM; Hartikainen JM; Soini Y; Easton DF; Couch FJ
    Cancer Res; 2012 Apr; 72(7):1795-803. PubMed ID: 22331459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
    Travis RC; Reeves GK; Green J; Bull D; Tipper SJ; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    Lancet; 2010 Jun; 375(9732):2143-51. PubMed ID: 20605201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
    Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF;
    Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study identifies novel breast cancer susceptibility loci.
    Easton DF; Pooley KA; Dunning AM; Pharoah PD; Thompson D; Ballinger DG; Struewing JP; Morrison J; Field H; Luben R; Wareham N; Ahmed S; Healey CS; Bowman R; ; Meyer KB; Haiman CA; Kolonel LK; Henderson BE; Le Marchand L; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Eccles D; Evans DG; Peto J; Fletcher O; Johnson N; Seal S; Stratton MR; Rahman N; Chenevix-Trench G; Bojesen SE; Nordestgaard BG; Axelsson CK; Garcia-Closas M; Brinton L; Chanock S; Lissowska J; Peplonska B; Nevanlinna H; Fagerholm R; Eerola H; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Cox DG; Hall P; Wedren S; Liu J; Low YL; Bogdanova N; Schürmann P; Dörk T; Tollenaar RA; Jacobi CE; Devilee P; Klijn JG; Sigurdson AJ; Doody MM; Alexander BH; Zhang J; Cox A; Brock IW; MacPherson G; Reed MW; Couch FJ; Goode EL; Olson JE; Meijers-Heijboer H; van den Ouweland A; Uitterlinden A; Rivadeneira F; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Hopper JL; McCredie M; Southey M; Giles GG; Schroen C; Justenhoven C; Brauch H; Hamann U; Ko YD; Spurdle AB; Beesley J; Chen X; ; ; Mannermaa A; Kosma VM; Kataja V; Hartikainen J; Day NE; Cox DR; Ponder BA
    Nature; 2007 Jun; 447(7148):1087-93. PubMed ID: 17529967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men.
    Orr N; Cooke R; Jones M; Fletcher O; Dudbridge F; Chilcott-Burns S; Tomczyk K; Broderick P; Houlston R; Ashworth A; Swerdlow A
    PLoS Genet; 2011 Sep; 7(9):e1002290. PubMed ID: 21949660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.
    Warren H; Dudbridge F; Fletcher O; Orr N; Johnson N; Hopper JL; Apicella C; Southey MC; Mahmoodi M; Schmidt MK; Broeks A; Cornelissen S; Braaf LM; Muir KR; Lophatananon A; Chaiwerawattana A; Wiangnon S; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Sawyer EJ; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Guénel P; Truong T; Laurent-Puig P; Mulot C; Bojesen SE; Nielsen SF; Flyger H; Nordestgaard BG; Milne RL; Benítez J; Arias-Pérez JI; Zamora MP; Anton-Culver H; Ziogas A; Bernstein L; Dur CC; Brenner H; Müller H; Arndt V; Langheinz A; Meindl A; Golatta M; Bartram CR; Schmutzler RK; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Wang-Gohrke S; Eilber U; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov Y; Bermisheva M; Prokofyeva D; Zinnatullina G; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Hartikainen JM; Kataja V; Chenevix-Trench G; Beesley J; Chen X; ; ; Lambrechts D; Smeets A; Paridaens R; Weltens C; Flesch-Janys D; Buck K; Behrens S; Peterlongo P; Bernard L; Manoukian S; Radice P; Couch FJ; Vachon C; Wang X; Olson J; Giles G; Baglietto L; McLean CA; Severi G; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Mulligan AM; Weerasooriya N; Devilee P; Tollenaar RA; Martens JW; Seynaeve CM; Hooning MJ; Hollestelle A; Jager A; Tilanus-Linthorst MM; Hall P; Czene K; Liu J; Li J; Cox A; Cross SS; Brock IW; Reed MW; Pharoah P; Blows FM; Dunning AM; Ghoussaini M; Ashworth A; Swerdlow A; Jones M; Schoemaker M; Easton DF; Humphreys M; Wang Q; Peto J; dos-Santos-Silva I
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1783-91. PubMed ID: 22859399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of breast cancer susceptibility loci in Chinese women.
    Long J; Shu XO; Cai Q; Gao YT; Zheng Y; Li G; Li C; Gu K; Wen W; Xiang YB; Lu W; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2357-65. PubMed ID: 20699374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association analysis between breast cancer genetic variants and mammographic density in a large population-based study (Determinants of Density in Mammographies in Spain) identifies susceptibility loci in TOX3 gene.
    Fernandez-Navarro P; Pita G; Santamariña C; Moreno MP; Vidal C; Miranda-García J; Ascunce N; Casanova F; Collado-García F; Herráez B; González-Neira A; Benítez J; Pollán M
    Eur J Cancer; 2013 Jan; 49(2):474-81. PubMed ID: 23021931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.